Top

Pathology & Oncology Research

Published in:

01-06-1997 | Article

HLA-DR2 frequency increase in severe aplastic anemia patients is mainly attributed to the prevalence of DR15 subtype

Authors: Sergey I Kapusttn, Tamara I Popova, Anton A Lyschov, Alexander V Togo, Kudrat M Abdulkadyrov, Michail N Blinov

Published in: Pathology & Oncology Research | Issue 2/1997

Title: HLA-DR2 frequency increase in severe aplastic anemia patients is mainly attributed to the prevalence of DR15 subtype
Authors: Sergey I Kapusttn
Tamara I Popova
Anton A Lyschov
Alexander V Togo
Kudrat M Abdulkadyrov
Michail N Blinov
Publication date: 01-06-1997
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 2/1997
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/BF02907803

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/1997

Spontaneously curing anaplastic carcinoma in the lymph node

Molecular events as targets of anticancer drug therapy

Allelic losses from chromosome 17 in human osteosarcomas

Specificity of retroviral proteinases based on substrates containing tyrosine and proline at the site of cleavage

Changes in benign to malignant ratio of surgically treated breast diseases in a district hospital

Polychondritis terminating in Eosinophilic Leukemia

Keynote webinar | Spotlight on antibody–drug conjugates in cancer